His clinical and research interests are in pediatric soft tissue, vascular and skeletal anomalies and tumors, wherein he has been instrumental in collaborative efforts describing several new vascular anomalies as well as identifying the genetic basis for more than a dozen malformations and tumors. His research has led to a successful clinical trial and the widespread use of sirolimus for the treatment of lymphatic malformation disorders.